MAPT and Alzheimer disease: Although tau‐IP aggregates were purified with antibody to native tau, the increase of tau peptides in AD samples was largely due to higher abundance of tau phosphopeptides in AD; the fraction of phosphorylated tau peptides was >52% for AD, vs. 22% for NC (P < 10−11).